TargetMol

Sch 34826

Product Code:
 
TAR-T28715
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T28715-5mg5mg£850.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T28715-50mg50mg£1,661.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T28715-100mg100mg£2,079.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Sch 34826 is a potent, selective neutral endopeptidase inhibitor.
CAS:
105262-04-2
Formula:
C27H34N2O7
Molecular Weight:
498.576
Purity:
0.98
SMILES:
CC1(C)OCC(COC(=O)C(Cc2ccccc2)N[C@@H](Cc2ccccc2)C(=O)NCCC(O)=O)O1

References

1. Kavaliers M, Innes DG. Sex differences in the antinociceptive effects of the enkephalinase inhibitor, SCH 34826. Pharmacol Biochem Behav. 1993 Dec;46(4):777-80. PubMed PMID: 8309954. 2. Saksida LM, Galea LA, Kavaliers M. Antinociceptive effects of the enkephalinase inhibitor, SCH 34826, in the snail, Cepaea nemoralis. Peptides. 1993 Jul-Aug;14(4):763-5. PubMed PMID: 8234022. 3. Monopoli A, Ongini E, Cigola E, Olivetti G. The neutral endopeptidase inhibitor, SCH 34826, reduces left ventricular hypertrophy in spontaneously hypertensive rats. J Cardiovasc Pharmacol. 1992 Sep;20(3):496-504. PubMed PMID: 1279298. 4. Stewart AG, Sheedy W, Thompson JS, Morice AH. Effects of SCH 34826, a neutral endopeptidase inhibitor, on hypoxic pulmonary vascular remodelling. Pulm Pharmacol. 1992 Jun;5(2):111-4. PubMed PMID: 1535251.